Woodline Partners’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
+846,399
| New | +$1.86M | 0.01% | 731 |
|
|
2025
Q1 | – | Sell |
-838,419
| Closed | -$1.06M | – | 932 |
|
|
2024
Q4 | $1.06M | Sell |
838,419
-62,002
| -7% | -$78.7K | 0.01% | 747 |
|
|
2024
Q3 | $3.07M | Sell |
900,421
-70,070
| -7% | -$239K | 0.03% | 436 |
|
|
2024
Q2 | $4.53M | Buy |
970,491
+75,491
| +8% | +$353K | 0.04% | 347 |
|
|
2024
Q1 | $6.64M | Sell |
895,000
-401
| -0% | -$2.98K | 0.06% | 331 |
|
|
2023
Q4 | $9.07M | Sell |
895,401
-2,364,309
| -73% | -$24M | 0.1% | 239 |
|
|
2023
Q3 | $25.4M | Buy |
3,259,710
+510,405
| +19% | +$3.98M | 0.3% | 99 |
|
|
2023
Q2 | $22.6M | Buy |
2,749,305
+102,685
| +4% | +$845K | 0.27% | 110 |
|
|
2023
Q1 | $19.2M | Buy |
2,646,620
+567,872
| +27% | +$4.12M | 0.26% | 107 |
|
|
2022
Q4 | $18.4M | Buy |
+2,078,748
| New | +$18.4M | 0.25% | 122 |
|
|
2022
Q3 | – | Sell |
-1,016,891
| Closed | -$12M | – | 772 |
|
|
2022
Q2 | $12M | Buy |
1,016,891
+994,020
| +4,346% | +$11.8M | 0.19% | 151 |
|
|
2022
Q1 | $435K | Buy |
+22,871
| New | +$435K | 0.01% | 521 |
|